Bromocriptine for the treatment of peripartum cardiomyopathy: welcome on BOARD

Eur Heart J. 2017 Sep 14;38(35):2680-2682. doi: 10.1093/eurheartj/ehx428.

Authors

Mattia Arrigo¹, Alice Blet², Alexandre Mebazaa^{2

3}

Affiliations

¹ Department of Cardiology, University Heart Center, University Hospital Zurich, Zurich, Switzerland.
² APHP, Department of Anaesthesiology and Intensive Care, Lariboisière and Saint Louis University Hospitals, Paris, France; Inserm UMR-S 942, Paris, France.
³ University Paris Diderot, Sorbonne Paris Cité, Paris, France.

PMID: 28934838
DOI: 10.1093/eurheartj/ehx428

No abstract available

Publication types

Editorial
Comment

MeSH terms

Bromocriptine
Cardiomyopathies*
Female
Humans
Peripartum Period
Puerperal Disorders*

Substances

Bromocriptine